Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…
LECTRA: Monthly declaration of the total number of shares and voting rights composing the company’s capital (at October 31th, 2024)
Monthly declaration of the total number of shares and voting rights composing…
Quadient S.A. – Monthly information on number of shares and voting rights
Accessibility: Skip TopNav November 13, 2024 11:45 ET | Source: QUADIENT Monthly…
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data…
Monthly information related to total number of voting rights and shares composing the share capital October 31, 2024
Monthly information related to total number of voting rights and shares composing…
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 7 November 2024 — This company announcement discloses the data…
Ipsen – October 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
Nokia Corporation: Repurchase of own shares on 01.11.2024
Nokia CorporationStock Exchange Release1 November 2024 at 22:30 EET Nokia Corporation: Repurchase…